Biktarvy, formally known as bictegravir, is a effective single-tablet therapy for controlling HIV infection. This drug integrates three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the virus's ability to replicate within the body, significantly lowering the viral load. For many